|
C8ORF44 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.670100E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.385900E-02 |
| Normal-vs-Stage2 |
3.178400E-01 |
| Normal-vs-Stage3 |
8.688300E-02 |
| Normal-vs-Stage4 |
7.804400E-01 |
| Stage1-vs-Stage2 |
6.308600E-01 |
| Stage1-vs-Stage3 |
9.542600E-01 |
| Stage1-vs-Stage4 |
1.825750E-01 |
| Stage2-vs-Stage3 |
7.240600E-01 |
| Stage2-vs-Stage4 |
5.242200E-01 |
| Stage3-vs-Stage4 |
2.375800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.787600E-02 |
| Normal-vs-AfricanAmerican |
7.633200E-01 |
| Normal-vs-Asian |
2.427500E-02 |
| Caucasian-vs-AfricanAmerican |
2.026000E-01 |
| Caucasian-vs-Asian |
7.699500E-03 |
| AfricanAmerican-vs-Asian |
6.871800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.939640E-02 |
| Normal-vs-Female |
5.303800E-01 |
| Male-vs-Female |
4.021700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.945200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.032600E-01 |
| Normal-vs-Age(61-80Yrs) |
4.318300E-02 |
| Normal-vs-Age(81-100Yrs) |
3.166000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.112400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.347400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.196400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.739200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.091600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.941400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.039050E-01 |
| Normal-vs-Grade 2 |
8.736100E-02 |
| Normal-vs-Grade 3 |
1.953790E-01 |
| Normal-vs-Grade 4 |
1.239150E-01 |
| Grade 1-vs-Grade 2 |
1.863620E-02 |
| Grade 1-vs-Grade 3 |
3.424300E-02 |
| Grade 1-vs-Grade 4 |
4.117700E-02 |
| Grade 2-vs-Grade 3 |
6.116800E-01 |
| Grade 2-vs-Grade 4 |
8.258400E-01 |
| Grade 3-vs-Grade 4 |
5.754600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.084990E-01 |
| Normal-vs-ccB subtype |
3.501600E-02 |
| ccA subtype-vs-ccB subtype |
4.249600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.265200E-01 |
| Normal-vs-N1 |
1.727410E-01 |
| N0-vs-N1 |
4.822800E-01 |
|
|
